Cision will be delisted from NASDAQ OMX Stockholm on August

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cision will be delisted from NASDAQ OMX Stockholm on August 15, 2014 and listed on NGM Nordic MTF

As previously announced, Cision AB (publ) has applied for delisting of the company’s shares from NASDAQ OMX Stockholm. The company has also previously announced its intention to see to it that the company’s shares can be listed on another market place following the last day of trading on NASDAQ OMX Stockholm. Cision has applied and been approved for listing on NGM Nordic MTF provided that the dispersion requirement for this market place is fulfilled in respect of the company’s shares in connection with the first day of trading. Cision has also been informed that NASDAQ OMX Stockholm has decided that the last day of trading in the Cision shares on NASDAQ OMX Stockholm will be August 15, 2014 provided that Blue Canyon Holdings AB’s public offer to the shareholders of Cision has then been declared unconditional. In accordance with the above, the first day of trading on NGM Nordic MTF will be August 18, 2014. In case the dispersion requirement for NGM Nordic MTF is not fulfilled, the last day of trading on NASDAQ OMX Stockholm will be announced separately as soon as this has been finally established. _________________ Stockholm, July 4, 2014 The Board of Directors of Cision AB (publ) For further information, please contact: Magnus Thell, interim President and CEO, telephone +46 8 507 410 00 E-mail: investorrelations@cision.com Charlotte Hansson, CFO, telephone +46 8 507 410 00 E-mail: investorrelations@cision.com Cision AB (publ), P.O. Box 24194, SE-104 51 Stockholm, Sweden Corp Identity No. 556027-9514 Telephone: +46 8 507 410 00 http://corporate.cision.com The information provided herein is such that Cision AB (publ) is obligated to disclose pursuant to the Swedish Securities Markets Act (SFS 2007:528) and/or the Swedish Financial Instruments Trading Act (SFS 1991:980). The information was submitted for publication at 15:00 CEST on July 4, 2014. N.B. The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Cision is a leading provider of cloud-based PR software, services and tools for the marketing and public relations industry. Marketing and PR professionals use our products to help manage all aspects of their brands – from identifying key media and influencers to connecting with audiences; monitoring traditional and social media; and analyzing outcomes. Journalists, bloggers, and other influencers use Cision’s tools to research story ideas, track trends, and maintain their public profiles. Cision is present in Europe, North America and Asia and quoted on the Stockholm Stock Exchange with revenue of approx. SEK 0.9 billion in 2013. For more information, visit www.cision.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 288

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 343

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 451

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 295

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 289

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Addressing the Housing Crisis: Federal Funding Efforts

Updated Category News Views 313

Tackling Canada's Housing Crisis Canada is actively working to combat its housing crisis, with significant measures aimed at helping those who are homeless. While there’s a sense of hope in the air, the presence of encampments underscores the immediate need for long-lasting solutions. The federal government is stepping up its efforts, showing a dedicated resolve to...

Continue Reading
Rigetti Computing Readies for Third Quarter Results Announcement

Updated Category News Views 65

Rigetti Computing Announces Third Quarter Financial Results Rigetti Computing, Inc. (Nasdaq: RGTI), recognized as a leader in hybrid quantum-classical computing, has exciting news regarding its financial performance. The company is set to release its financial results for the third quarter of 2024 on a specified date, marking an important moment for stakeholders and...

Continue Reading
Novartis Reports Outstanding Q3 Performance and 2025 Outlook

Updated Category News Views 545

Solid Q3 Performance by Novartis In a significant announcement, Novartis reported an impressive growth in net sales and core operating income for the third quarter. During this period, the company's net sales reached USD 13.9 billion, reflecting a growth of 7% on a constant currency basis and an 8% increase in USD terms. Core operating income showed a similar trajectory,...

Continue Reading
Forestar Group Inc. Set to Announce First Quarter Earnings Soon

Updated Category News Views 134

Forestar Group Inc. to Announce First Quarter Earnings Forestar Group Inc. (NYSE: FOR) is preparing to share key financial results for its first quarter, marking the end of December 2024. This eagerly awaited announcement will take place shortly before the markets open on the designated day. Shareholders and interested parties will have the opportunity to hear about the...

Continue Reading
ImCheck Therapeutics Secures EMA Orphan Drug Designation

Updated Category News Views 196

ImCheck Therapeutics Secures EMA Orphan Drug Designation ImCheck Therapeutics has exciting news as it recently announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to ICT01, its flagship treatment aimed at addressing acute myeloid leukemia (AML). This development, coming shortly after a similar designation from the U.S. FDA,...

Continue Reading